Press

Red Light Holland Expected Merger Partner Creso Pharma Completes Acquisition of Halucenex Life Sciences Inc

Jul 15 • 4 min read

Quick Take: Red Light Holland’s expected merger partner Creso Pharma Ltd. has announced the acquisition of Halucenex Life Sciences Ltd. Red Light Holland Corp. (CSE: TRIP), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce…

Awakn Life Sciences Initiates Research Program to Further Develop Ketamine-Assisted Therapies for Treating Addiction

Jul 15 • 3 min read

Quick Take: Awkn has announced that they will be starting a new program to study and demonstrate ketamine’s effectiveness in treating multiple addictions. Awakn Life Sciences Corp. (NEO: AWKN), a biotechnology company with clinical operations developing and delivering psychedelic medicines to better treat addiction, announced that it will undertake a program of clinical research designed…

Clearmind Announces Changes To Senior Management As It Accelerates Development Of Its IP Portfolio

Jul 14 • 3 min read

Quick Take: Clearmind has appointed four new members to its senior management team, including CEO, COO, CFO, and special advisor for innovation. Clearmind Medicine Inc. (CSE: CMND), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, is pleased to announce changes to its…

Red Light Holland Sells ~350,000 Grams of Magic Truffles and Increases Points of Sale for iMicrodose Packs

Jul 14 • 3 min read

Quick Take: Red Light Holland has sold approx. 350,000 grams of packaged Magic Truffles and now has iMicrodose Packs for sale in 30 Smart Shops, including brick and mortar stores. Red Light Holland Corp. (CSE: TRIP), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles to the…

Cybin Expands to Europe and Provides Update on Intellectual Property Portfolio

Jul 9 • 2 min read

Quick Take: Cybin Inc. has announced their plans for operational expansion to Europe. These plans include moving its intellectual portfolio to its wholly-owned Ireland-based subsidiary. Cybin Inc. (NEO: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, today announced the scaling up of its European operations and research activities with various academic and clinical research organizations,…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435